ScienceDex / Researcher record
Paul S. Aisen
- University of Southern California · Neurology (NIH department code)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 1% Funded
- R01 Holder
- Multi-Institutional
- Early Career
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $59,431,759 | 5 | #9 |
| 2025 | $54,574,032 | 6 | #11 |
| 2026 | $82,301,662 | 5 | #2 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected5 records
- FY20256 records
- FY20265 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 2059843Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Neurology
FY2024 award records by amount
NIH award records listing Paul S. Aisen as a PI. Multi-PI records show the full award amount for context.
- 5U24AG057437-07U24Contact PIAlzheimer's Clinical Trials Consortium (ACTC)University of Southern California · Neurology (NIH department code)$28.4Maward amount
- 5R01AG065248-03R01Co-investigatorRandomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 Months$13.1Maward amount
- 5R01AG061848-05R01Contact PICombination anti-amyloid therapy for preclinical Alzheimer's diseaseUniversity of Southern California · Neurology (NIH department code)$8.7Maward amount
- $6.5Maward amount
- 5R01AG063689-05R01Co-investigatorAnti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension StudyBrigham and Women's Hospital · Neurology (investigator's affiliation)$2.6Maward amount
Award organizations
Organizations that administered FY2024 awards listing Paul S. Aisen as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Southern California
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024$10M Cumulative Funding
- 2024$25M Cumulative Funding
- 2024$50M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #9
- 2024Entered Top 25% NationallyRanked #9
- 2024Entered Top 10% NationallyRanked #9
- 2024Entered Top 5% NationallyRanked #9
- 2024Entered Top 1% NationallyRanked #9
- 2025$100M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 4 institutions
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Paul S. Aisen.